Biotech Investors & VC Firms in United Arab Emirates
13 firms in this list, with a median first check of $1M. 5 of them lead rounds. Generated from verified public data and updated continuously.
Hub71
Abu DhabiPre-Seed–Series A
6 people
Elmirate Capital
DubaiSeed–Late Stage$1M – $250M
Bioscience Equity Partners
DubaiLate Stage
1 person
Antler
SingaporePre-Seed–Series C$125K
327 people
General Atlantic
New YorkSeries B–Late Stage$10M – $1B
500 people
Blume Ventures
MumbaiSeed–Series B$50K – $300K
34 people
Antler Australia
SydneyPre-Seed–Series C$3M – $10M
17 people
Forepont Capital Partners
New YorkPre-Seed–Series A
24 people
Expara
SingaporePre-Seed–Series A
18 people
Xenia Venture Capital
Tel AvivSeed–Series A
5 people
Worthwhile Industries Campuses
TorontoLate Stage
Ela Capital
TorontoPre-Seed–Growth
3 people
Qatar Foundation
DohaPre-Seed
Frequently asked questions
- Who are the top biotech investors & vc firms in united arab emirates?
- Top biotech investors & vc firms in united arab emirates include Hub71, Elmirate Capital, Bioscience Equity Partners, Antler, General Atlantic, Blume Ventures, Antler Australia, Forepont Capital Partners — 13 firms in total meet the criteria.
- What is the typical first check among biotech investors & vc firms in united arab emirates?
- The median first check among the 13 biotech investors & vc firms in united arab emirates tracked here is $1M.
- How many biotech investors & vc firms in united arab emirates lead rounds?
- 5 of the 13 biotech investors & vc firms in united arab emirates tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (12941)Investors & VC Firms in United States (11979)Investors & VC Firms in Europe (5859)Investors & VC Firms in Global (4787)AI & Machine Learning Investors & VC Firms (4629)Fintech Investors & VC Firms (4588)SaaS Investors & VC Firms (4239)Healthtech Investors & VC Firms (4227)Enterprise Software Investors & VC Firms (4136)Crypto & Web3 Investors & VC Firms (3986)
Data sourced from public filings and firms' own websites — see our methodology.









































